National Cabinet met today to discuss Australia’s COVID-19 response, recent outbreaks of COVID-19 and the Australian COVID-19 Vaccine Strategy.
Chief Medical Officer Professor Paul Kelly provided an update on the current COVID-19 situation and health response across Australia including new principles for test, trace, isolate and quarantine as well as public health and safety measures.
Since the beginning of the pandemic there have been 177,393 confirmed cases in Australia and, sadly, 1,795 people have died. More than 44 million tests have been undertaken. Testing has increased nationally over recent days with 1,088,293 tests reported in the past 7 days.
Globally there have been over 248 million cases and sadly over 5 million deaths, with 502,386 new cases and 7,801 deaths reported in the last 24 hours. The COVID-19 pandemic continues to surge in many countries around the world.
Australia’s COVID-19 vaccine roll out continues to expand. To date 36.4 million doses of COVID-19 vaccines have been administered in Australia, including a record 181,833 doses in the previous 24 hours.
In the previous 7 days, more than 1.1 million vaccines have been administered in Australia. More than 89 per cent of the Australian population aged 16 years and over have now had a first dose of a COVID-19 vaccine, including over 95 per cent of over 50 year olds and more than 99 per cent of over 70 year olds.
More than 79 per cent of Australians aged 16 years and over are now fully vaccinated, including more than 87 per cent of over 50 year olds and more than 92 per cent of Australians over 70 years of age.
Lieutenant General John Frewen, DSC, AM, Coordinator General of the National COVID Vaccine Taskforce (Operation COVID Shield) also reported on work underway to support a higher level of vaccination uptake amongst Indigenous Australians. All leaders reiterated the importance of Australians, especially those in vulnerable groups, to get two doses of a COVID-19 vaccination.
Lt General Frewen, Commonwealth Chief Medical Officer Professor Paul Kelly and Secretary of the Commonwealth Department of Health Professor Brendan Murphy also provided an update on boosters and third dose vaccinations.
National Cabinet and the National Federation Reform Council agreed to meet next on Friday 10 December.
Vaccination and Booster Plans
National Cabinet discussed the roll out of the booster program following approvals by the Therapeutic Goods Administration (TGA) and Australian Technology Advisory Group on Immunisation (ATAGI) supporting COVID-19 boosters for Australians aged 18 and over who have received two doses at least six months ago.
The booster program has commenced for immunocompromised Australians and high priority groups. Already around 150,000 third doses have been administered. The booster program will open more broadly on 8 November 2021.
The booster roll out will continue to utilise the existing vaccination infrastructure with around 10,000 general practices and pharmacies, augmented by in-reach services and state clinics across Australia. Commonwealth funding under the vaccine schedule of the National Partnership on COVID-19 Response will continue.
Lt General Frewen provided an update on plans to accelerate the roll out for Aboriginal and Torres Strait Islander people across all jurisdictions in order to deliver vaccinations in partnership with Aboriginal Community Controlled Health Organisations (ACCHOs) and relevant jurisdictions. With supplies available, there are significant opportunities available to be vaccinated across urban, rural, remote and very remote areas. Hesitancy continues to be a factor in low uptake, with all jurisdictions introducing measures to reduce hesitancy.
National Cabinet received advice from the Chief Medical Officer on emerging scientific evidence of the benefits of vaccinating for 5-11 year olds. A vaccination program for children aged 5-11 years will be implemented, if supported by upcoming regulatory decisions from the TGA and advice from ATAGI.
Ensuring COVID-19 Outbreak Readiness for Indigenous Communities
National Cabinet noted the risks of COVID-19 outbreaks for Indigenous communities from the easing restrictions in Phases B and C of the National Plan to transition Australia’s National COVID-19 Response, particularly where vaccination rates are lower, including in regional and remote communities.
National Cabinet noted recent developments provided an opportunity to update existing outbreak preparedness plans, including revised Communicable Diseases Network Australia (CDNA) National Guidance for remote Aboriginal and Torres Strait Islander Communities for COVID-19, due to be updated in early November; revised Doherty modelling of outbreak scenarios which take higher vaccination rates into account; and learnings from recent outbreaks.
National Cabinet agreed that the Commonwealth and all jurisdictions will update outbreak management plans, in partnership with the Aboriginal and Torres Strait Islander community sector, and ensure that Emergency Management Australia (EMA) is consulted in the updated planning, and that plans include timely requests for support through EMA where needed, particularly to support localised vaccine acceleration and/or establishing quarantine facilities.
The Commonwealth and all jurisdictions will return to National Cabinet in December with updated outbreak management plans for final agreement.
National Plan to Transition Australia’s COVID-19 Response
National Cabinet received its final update from Professor Jodie McVernon from the Doherty Institute on the second phase of modelling work under the National Plan to transition Australia’s National COVID-19 Response.
National Cabinet noted that this modelling, which incorporates updated parameters and recent evidence, confirms that Doherty’s previous findings regarding the thresholds for moving to Phases B and C of the National Plan remain robust.
The modelling also confirmed the importance of high vaccine coverage in the Australian population, combined with public health strategies. Streamlined public health responses, such as testing and isolating only close contacts, combined with high vaccination rates, can also reduce transmission risks. It also finds shorter periods of quarantine below 14 days may be effective for vaccinated people testing positive.
Doherty found that localised health strategies may be required with high case numbers and for key high risk groups, areas and settings, including Indigenous communities and in schools.
The modelling found that cases resulting from international arrivals would be manageable once 80 per cent or more of the eligible Australian population is fully vaccinated.
Doherty found that surveillance in high risk areas to identify outbreaks early and contact management can reduce infections, keep schools open and minimise disruptions to face-to-face learning.
The Doherty Institute, in consultation with the CDNA and the AHPPC, identified strategies to streamline and focus test, trace, isolate and quarantine responses as jurisdictions move into Phases B and C of the National Plan in the context of increasing caseloads, the current Delta strain and high vaccine coverage.
National Cabinet thanked the Doherty Institute and Professor McVernon for their work which has informed the development and implementation of the National Plan.
The Taskforce summary of these findings is attached and will be available on www.pmc.gov.au. Detailed modelling reports will be released by The Doherty Institute over the coming days.
Doherty Institute COVID-19 modelling: 2nd tranche [PDF 651 KB]
Living with COVID-19 – Revised Test, Trace, Isolate and Quarantine (TTIQ) and Public Health and Social Measures (PHSMs)
National Cabinet received updated advice from AHPPC on test, trace, isolate and quarantine (TTIQ) measures and public health and social measures (PHSMs) in place during the transition to living with COVID-19.
National Cabinet agreed to the AHPPC principles of test, trace, isolate and quarantine (TTIQ) applicable from Phase B of the National Plan, and the AHPPC principles to guide the application of public health and social measures (PHSM) appropriate to maintain disease control.
National Cabinet further agreed to adopt the baseline PHSM with the implementation of Phase C of the National Plan, with flexibility to apply variable PHSM in communities with less than 80 per cent vaccination coverage, and as required by specific epidemiological circumstances.
National Cabinet also agreed, from Phase C, to adopt a risk-based approach to changes to quarantine arrangements for contacts, including differential arrangements for fully vaccinated close contacts.
